Analysis of diagnostic and therapeutic strategies in advanced cardiac light-chain amyloidosis-Reference-Cited by-同舟云学术

Analysis of diagnostic and therapeutic strategies in advanced cardiac light-chain amyloidosis

Published:2016-08 Issue:8 Volume:35 Page:995-1002
ISSN:1053-2498
Container-title:The Journal of Heart and Lung Transplantation
language:en
Short-container-title:The Journal of Heart and Lung Transplantation

Author:

Sayago Inés^ORCID,Krsnik Isabel,Gómez-Bueno Manuel,García-Pavía Pablo,Jaramillo Natalia,Salas Clara,Mingo Susana,Oteo Juan F.,Alonso-Pulpón Luis,Segovia Javier

Publisher

Elsevier BV

Subject

Transplantation,Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference22 articles.

1. Cardiac amyloidosis: a treatable disease, often overlooked;Falk;Circulation,2011

2. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis;Gertz;Am J Hematol,2005

3. Update on treatment of light chain amyloidosis;Mahmood;Haematologica,2014

4. Treatment with intravenous melphalan and dexamethasone is not able to overcome the poor prognosis of patients with newly diagnosed systemic light chain amyloidosis and severe cardiac involvement;Dietrich;Blood,2010

5. Lenalidomide, melphalan and dexamethasone in a population of patients with immunoglobulin light chain amyloidosis with high rates of advanced cardiac involvement;Dinner;Haematologica,2013

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Defining echocardiographic predictors of outcome in cardiac amyloidosis by subtype;Current Problems in Cardiology;2024-09

2. Outcomes of Modified Mayo Stage IIIa and IIIb Cardiac Light-Chain Amyloidosis: Real-World Experience in Clinical Characteristics and Treatment—67 Patients Multicenter Analysis;Cancers;2024-04-21

3. Current barriers and recommendations on the diagnosis of transthyretin amyloid cardiomyopathy: a Delphi study;Frontiers in Cardiovascular Medicine;2024-01-25

4. Multidisciplinary amyloidosis care in the era of personalized medicine;Frontiers in Neurology;2022-10-13

5. Systematic literature review of evidence in amyloid light-chain amyloidosis;Journal of Comparative Effectiveness Research;2022-04